Sai Life Sciences shares jump 9%, multibagger stock rallies 19% in 3 days after Q2 results. Why Jefferies hiked target price
Sai Life Sciences shares hit a fresh 52-week high on Monday after strong Q2 results and bullish brokerage commentary. Jefferies retained its Buy rating and raised its target price to Rs 2,050, citing healthy CRO and CDMO growth, a strengthening pipeline and improved earnings prospects.
Full story
Read the full story at The Economic Times (India) ↗
Continue reading this story on The Economic Times (India), the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
